givosiran sodium

FDA Drug Profile — GIVLAARI

Drug Details

Generic Name
givosiran sodium
Brand Names
GIVLAARI
Application Number
NDA212194
Sponsor
Agilent Technologies Inc.
NDC Codes
2
Dosage Forms
POWDER, INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
GIVOSIRAN, GIVOSIRAN SODIUM

Indications and Usage

1 INDICATIONS AND USAGE GIVLAARI is indicated for the treatment of adults with acute hepatic porphyria (AHP). GIVLAARI is an aminolevulinate synthase 1-directed small interfering RNA indicated for the treatment of adults with acute hepatic porphyria (AHP). ( 1 )